The Energy Flux Study

Overview

The focus of this randomized clinical trial study is an examination of the effects of maintaining energy balance at different energy fluxes. It will address the primary question: Are there increased health benefits related to body composition and metabolic function associated with maintaining energy balance at a high energy flux as compared to a low energy flux?

Full Title of Study: “Evaluation of Energy Balance at High vs. Low Energy Flux – Energy Flux Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 2014

Detailed Description

We will randomly assign 75 sedentary but healthy individuals to one of two exercise groups or a non-exercise group. We will follow the individuals for 6 months during the intervention period. Both groups will maintain weight by matching energy intake and expenditure (thus the exercise group will consume more calories).

Interventions

  • Other: Energy Flux Exercise Intervention
    • Comparison of high, medium and low energy flux groups with all groups matching energy intake and expenditure

Arms, Groups and Cohorts

  • Experimental: High Energy Flux
    • Energy Flux Exercise Intervention: 7kcal/kg/day at 5 days/week of energy expenditure and matching energy intake
  • Experimental: Medium Energy Flux
    • Energy Flux Exercise Intervention: 3.5kcal/kg/day at 5 days/week of energy expenditure and matching energy intake
  • No Intervention: Low Energy Flux
    • No Intervention: maintain normal lifestyle

Clinical Trial Outcome Measures

Primary Measures

  • Changes in anthropometrics
    • Time Frame: From baseline to 6 months
    • Changes in lean and fat mass

Participating in This Clinical Trial

Inclusion Criteria

  • BMI <35 – 21-45 years of age – Fasting plasma glucose <126 mg/dl – Current medications must have been prescribed for 3 or more months and stable – Internet access – Able to participate in a somewhat strenuous physical exercise program – Able to provide informed consent for participation in a research study Exclusion Criteria:

  • Currently participating in a weight loss or exercise intervention / program – Planning to have weight loss surgery – Weight change >5 lb in last 12 months – Currently taking any of the following: hormone replacement therapy, beta blockers, allergy shots or systematic corticosteroids (except inhalers) – Significant cardiovascular disease or disorders including but not limited to: serious arrhythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, acute, chronic or recurrent thrombophlebitis, Stage II or Stage III hypertension, myocardial infarction or abnormal exercise stress test. – Medical history with presence of significant conditions or disease that may interfere with study, recent surgery – Pregnant or actively trying to become pregnant – Gave birth in the last 12 months or <6 months post-lactation – > 90th percentile on the Brief Symptom Inventory [BSI] – Planning to move from the area in the next 8 months – Other medical, psychiatric or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability ot follow the intervention protocol. Upon identification of individuals with suicidal ideation or other dangerous conditions, the individual will be contacted and told to immediately go to a medical emergency room.

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of South Carolina
  • Collaborator
    • The Coca-Cola Company
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sarah Schumacher, Director – University of South Carolina
  • Overall Official(s)
    • Gregory Hand, Ph.D, Principal Investigator, University of South Carolina
    • Steven Blair, Ph.D, Principal Investigator, University of South Carolina

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.